EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study

Ozum Tutal, Bora Gulhan, Emine Atayar, Selcuk Yuksel, Z Birsin Ozcakar, Oguz Soylemezoglu, Seha Saygili, Salim Caliskan, Mihriban Inozu, Esra Baskin, Ali Duzova, Mutlu Hayran und 2 weitere

Nephron · 2024

DOI: 10.1159/000528258 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nephron, 2024. Verfasst von Ozum Tutal und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Polycystic Kidney, Autosomal Recessive, Mutation, Receptors, Cell Surface. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autosomal recessive polycystic kidney disease (ARPKD) is associated with pathogenic variants in the PKHD1 gene. Autosomal dominant polycystic kidney disease (ADPKD) is mainly associated with pathogenic variants in PKD1 or PKD2. The present study aimed to identify the clinical and genetic features of Turkish pediatric ARPKD and ADPKD patients.

Methods

This multicenter, retrospective cohort study included 21 genetically confirmed ARPKD and 48 genetically confirmed ADPKD patients from 7 pediatric nephrology centers. Demographic features, clinical, and laboratory findings at presentation and during 12-month intervals were recorded.

Results

The median age of the ARPKD patients at diagnosis was lower than the median age of ADPKD patients (10.5 months [range: 0–15 years] vs. 5.2 years [range: 0.1–16 years], respectively, [p = 0.014]). At the time of diagnosis, the median eGFR in the ARPKD patients was lower compared to that of ADPKD patients (81.6 [IQR: 28.7–110.5] mL/min/1.73 m2 and 118 [IQR: 91.2–139.8] mL/min/1.73 m2, respectively, [p = 0.0001]). In total, 11 (52.4%) ARPKD patients had malnutrition; 7 (33.3%) patients had growth retardation at presentation; and 4 (19%) patients had both malnutrition and growth retardation. At diagnosis, 8 (16.7%) of the ADPKD patients had malnutrition, and 5 (10.4%) patients had growth retardation. The malnutrition, growth retardation, and hypertension rates at diagnosis were higher in the ARPKD patients than the ADPKD patients (p = 0.002, p = 0.02, and p = 0.0001, respectively). ARPKD patients with malnutrition and growth retardation had worse renal survival compared to the patients without (p = 0.03 and p = 0.01). Similarly, ADPKD patients with malnutrition had worse renal survival compared to the patients without (p = 0.002). ARPKD patients with truncating variants had poorer 3- and 6-year renal outcome than those carrying non-truncating variants (p = 0.017).

Conclusion

Based on renal survival analysis, type of genetic variant, growth retardation, and/or malnutrition at presentation were observed to be factors associated with progression to chronic kidney disease (CKD). Differentiation of ARPKD and ADPKD, and identification of the predictors of the development of CKD are vital for optimal management of patients with ARPKD or ADPKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantPolycystic Kidney, Autosomal RecessiveMutationReceptors, Cell SurfaceHumansRetrospective StudiesMaleFemaleChildInfantAdolescentChild, PreschoolTurkeyInfant, NewbornGlomerular Filtration RateCohort Studies

Stichwörter der Autor:innen

Autosomal dominant polycystic kidney diseaseAutosomal recessive polycystic kidney diseaseChronic kidney diseasePKD1PKD2PKHD1Prognosis

Substanzen

PKHD1 protein, humanReceptors, Cell Surface

Autor:innen und Institutionen

  • Department of Pediatrics, Hacettepe University, Ankara, Turkey.
  • Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University, Ankara, Turkey.
  • Nephrogenetics Laboratory, Division of Pediatric Nephrology, Department of Pediatrics Hacettepe University, Ankara, Turkey.
  • Division of Pediatric Nephrology, Department of Pediatrics, Pamukkale University, Denizli, Turkey.
  • Division of Pediatric Nephrology, Department of Pediatrics, Ankara University, Ankara, Turkey.
  • Division of Pediatric Nephrology, Department of Pediatrics, Gazi University, Ankara, Turkey.

Zitieren

APA

Tutal, O., Gulhan, B., Atayar, E., Yuksel, S., Ozcakar, Z. B., Soylemezoglu, O., Saygili, S., Caliskan, S., Inozu, M., Baskin, E., Duzova, A., Hayran, M., Topaloglu, R., & Ozaltin, F. (2024). The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study. Nephron. https://doi.org/10.1159/000528258

Vancouver

Tutal O, Gulhan B, Atayar E, Yuksel S, Ozcakar ZB, Soylemezoglu O, et al. The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study. Nephron. 2024. doi:10.1159/000528258

BibTeX
@article{Tutal2024,
  author = {Tutal, Ozum and Gulhan, Bora and Atayar, Emine and Yuksel, Selcuk and Ozcakar, Z Birsin and Soylemezoglu, Oguz and Saygili, Seha and Caliskan, Salim and Inozu, Mihriban and Baskin, Esra and Duzova, Ali and Hayran, Mutlu and Topaloglu, Rezan and Ozaltin, Fatih},
  title = {The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study},
  journal = {Nephron},
  year = {2024},
  doi = {10.1159/000528258}
}
Kostenlos starten →